Mild cognitive impairment (MCI) twenty years on
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Cognitive decline has commonly been considered an inevitable result of brain aging and has been of clinical interest principally because of related difficulties with everyday functioning. Since the 1990s the “normality” of age-related cognitive decline has been called into question, being commonly attributed to a number of underlying disorders. Numerous concepts have been proposed which link subclinical cognitive change to pathological states (mild cognitive disorder, mild neurocognitive disorder, mild cognitive impairment). Of these, mild cognitive impairment (MCI) has become the most popular, driven on the one hand by industrial interests seeking to extend new dementia treatments for a more prevalent subclinical syndrome, and on the other by researchers attempting to identify at-risk populations. MCI has been both criticized for “medicalizing” behavior still within normal limits (Stephan et al., 2008; Moreira et al., 2008) and welcomed in that it suggests cognitive decline with aging may not be inevitable, but rather due to abnormalities which could ultimately be treated. Recently, in both Europe (DuBois et al., 2007) and the USA (Albert et al., 2011), panels of experts have scrutinized the concept of MCI and more broadly the pre-dementia stages of neurodegenerative diseases and offered new research diagnostic criteria. These proposed criteria have highlighted the (potential) value of biomarkers in assisting diagnosis, although some have considered the elevation of biomarkers to this level of importance in diagnosing disease before dementia develops to be premature given both the extent and quality of diagnostic biomarker data currently available (McShane et al., 2011a; 2011b).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659 · cited 2×
“The application of the concept to general practice and general population samples has subsequently shown cumulative conversion rates to any type of dementia – even after long-term follow-up – to be only around 30%, with high rates of reversion to normal, and many subjects classified as non-MCI subsequently developing…”
BackgroundCSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176
Mild cognitive impairment in the elderly: Predictors of dementia
Flicker, C., Ferris, S. H., & Reisberg, B. (1991) · Neurology · doi:10.1212/wnl.41.7.1006 · Cited by 838
Visser, P. J., Verhey, F., Knol, D. L., Scheltens, P., Wahlund, L.-O., Freund-Levi, Y., Tsolaki, M., Minthon, L., Wallin, Å. K., Hampel, H., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70139-5 · Cited by 614
Morris, J. C., & Price, J. L. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:101 · Cited by 513 · cited 2×
“…by the National Institute on Aging workgroup led by Marilyn Albert and incorporating putative biomarkers (Albert et al., 2011) as convincing evidence indicates that neuropathology and neuronal loss are observable a decade before its manifestation as cognitive decline (Morris and Price, 2001).”
BackgroundRisk profiles for mild cognitive impairment and progression to dementia are gender specific
Artero, S., Ancelin, M.-L., Portet, F., Dupuy, A., Berr, C., Dartigues, J.-F., Tzourio, C., Rouaud, O., Poncet, M., Pasquier, F., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.136903 · Cited by 281
Self-citation
Cited by
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
Moore, E. M., Mander, A. G., Ames, D., Kotowicz, M. A., Carne, R. P., Brodaty, H., Woodward, M., Boundy, K., Ellis, K. A., Bush, A. I., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0229 · Cited by 349
A Systematic Review of the Public’s Knowledge and Understanding of Alzheimer’s Disease and Dementia
Cahill, S., Pierce, M., Werner, P., Darley, A., & Bobersky, A. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000102 · Cited by 265
A Deep Siamese Convolution Neural Network for Multi-Class Classification of Alzheimer Disease
Mehmood, A., Maqsood, M., Bashir, M., & Shuyuan, Y. (2020) · Brain Sciences · doi:10.3390/brainsci10020084 · Cited by 264
Physiological and functional consequences of caregiving for relatives with dementia
Fonareva, I., & Oken, B. S. (2014) · International Psychogeriatrics · doi:10.1017/s1041610214000039 · Cited by 249
Metadata
- Authors
- Ritchie, K., & Ritchie, C. W.
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-5
- ISSN
- 1041-6102 (ISSN-L)
- OpenAlex
- W2100349378
- Cited by
- 55
- References
- 6
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mild cognitive impairment (MCI) twenty years on. https://app.cochat.ai/papers/10.1017/s1041610211002067
- The paper
- Ritchie, K., & Ritchie, C. W. (2012). Mild cognitive impairment (MCI) twenty years on. International Psychogeriatrics. https://doi.org/10.1017/s1041610211002067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.